Applied DNA Sciences Inc
NASDAQ:BNBX

Watchlist Manager
Applied DNA Sciences Inc Logo
Applied DNA Sciences Inc
NASDAQ:BNBX
Watchlist
Price: 1.58 USD 4.64% Market Closed
Market Cap: $6.9m

Net Margin

-2 047.4%
Current
Declining
by 1 609%
vs 3-y average of -438.4%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-2 047.4%
=
Net Income
$-67.5m
/
Revenue
$3.3m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-2 047.4%
=
Net Income
$-67.5m
/
Revenue
$3.3m

Peer Comparison

Country Company Market Cap Net
Margin
US
Applied DNA Sciences Inc
NASDAQ:APDN
4m USD
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.2T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
223.2B USD
Loading...
US
Danaher Corp
NYSE:DHR
154.9B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
81.3T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
36.7B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.3B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
274.1B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
37.4B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.2B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
18.6B EUR
Loading...

Market Distribution

Lower than 95% of companies in the United States of America
Percentile
5th
Based on 15 072 companies
5th percentile
-2 047.4%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Applied DNA Sciences Inc
Glance View

Applied DNA Sciences, Inc. engages in the developing and marketing DNA-based technology solutions utilizing LinearDNA, large-scale polymerase chain reaction (PCR) based manufacturing platform. The company is headquartered in Stony Brook, New York and currently employs 78 full-time employees. The company went IPO on 2001-08-24. The firm is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. Applied DNA also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Company’s Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.

BNBX Intrinsic Value
7.55 USD
Undervaluation 79%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-2 047.4%
=
Net Income
$-67.5m
/
Revenue
$3.3m
What is Applied DNA Sciences Inc's current Net Margin?

The current Net Margin for Applied DNA Sciences Inc is -2 047.4%, which is below its 3-year median of -438.4%.

How has Net Margin changed over time?

Over the last 3 years, Applied DNA Sciences Inc’s Net Margin has decreased from -69.3% to -2 047.4%. During this period, it reached a low of -2 047.4% on Jun 30, 2025 and a high of -28.8% on Mar 31, 2023.

Back to Top